Cesca Therapeutics (KOOL) IDE Supplement for Phase III Clinical Trial Approved by FDA
Tweet Send to a Friend
Cesca Therapeutics Inc. (NASDAQ: KOOL) announced today that the Company received approval from the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
